AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

NADROPARINE

18 registrations across 1 African market— 18 active

Markets with NADROPARINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
FRAXODI
SOLUTION INJECTABLE
🇲🇦Moroccoactive
FRAXODI
SOLUTION INJECTABLE
🇲🇦Moroccoactive
FRAXIPARINE
SOLUTION INJECTABLE
🇲🇦Moroccoactive
FRAXODI
SOLUTION INJECTABLE
🇲🇦Moroccoactive
FRAXIPARINE
SOLUTION INJECTABLE
🇲🇦Moroccoactive
FRAXIPARINE
SOLUTION INJECTABLE
🇲🇦Moroccoactive
FRAXIPARINE
SOLUTION INJECTABLE
🇲🇦Moroccoactive
FRAXIPARINE
SOLUTION INJECTABLE
🇲🇦Moroccoactive
FRAXODI
SOLUTION INJECTABLE
🇲🇦Moroccoactive
FRAXIPARINE
SOLUTION INJECTABLE
🇲🇦Moroccoactive
FRAXIPARINE
SOLUTION INJECTABLE
🇲🇦Moroccoactive
FRAXIPARINE
SOLUTION INJECTABLE
🇲🇦Moroccoactive
FRAXIPARINE
SOLUTION INJECTABLE
🇲🇦Moroccoactive
FRAXIPARINE
SOLUTION INJECTABLE
🇲🇦Moroccoactive
FRAXODI
SOLUTION INJECTABLE
🇲🇦Moroccoactive
FRAXIPARINE
SOLUTION INJECTABLE
🇲🇦Moroccoactive
FRAXIPARINE
SOLUTION INJECTABLE
🇲🇦Moroccoactive
FRAXODI
SOLUTION INJECTABLE
🇲🇦Moroccoactive

NADROPARINE in Africa — Regulatory Overview

NADROPARINE is registered across 1 African markets with 18 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco. AfricaRegulatory refreshes this data daily from official government sources.

Of the 18 registrations, 18 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.